pharmaceutical industry

Accelerate and streamline research with diverse global populations and robust real-world data

As global demographics change and become more diverse, limited access to new patient populations has become an increasing barrier to the development and testing of new therapies.

Genauris has taken a new approach to address this challenge, building a global network of engaged patients, community partners, and robust health data to revolutionize the reach of clinical research.

  • Global reach and patient diversity: Genauris aims to connect millions of patients on our platform over the coming years. Our unique marketplace approach gives us access to patients that traditional research recruitment efforts can't reach, with a focus on underserved populations.
  • Robust, comprehensive health data: our platform is built on truly longitudinal health records that include clinical, lab, imagery and radiology, pharmacy, and more – and by integrating with existing EHR systems, offers a comprehensive, near real-time view of patient health and real-world evidence.

Genauris powers inclusive, efficient, and data-rich clinical trials with access to a globally diverse patient pool and tokenized real-world data. We improve recruitment, retention, and trial management – while generating real-world evidence that matters.

Comprehensive support for research studies and clinical trials

Through our network-based marketplace approach, Genauris is able to reach a truly broad global population – including among traditionally underserved populations.

Our platform increases patient engagement and retention compared to traditional models, offering significant improvement in study success rates. Simplified access to comprehensive patient health data and real-time outcomes reporting on our platform only further accelerates research efforts.

With Genauris, researchers can:

  • Recruit at scale from broad, globally diverse patient populations with higher retention and engagement
  • Engage community-level support for clinical trials, simplifying global site operations and management
  • Access extensive tokenized real-world health data
  • Leverage real-time ePROs and longitudinal health data to optimize trial design and improve outcomes
Pharmaceutical researchers

Real-world evidence and global health insights to optimize research and improve outcomes

Our goal is to reach tens of millions of patients and thousands of practitioners and public health partners globally, with special focus on traditionally underserved communities. Genauris' first-in-kind health marketplace dramatically simplifies health interactions and incentivizes long-term participation.

As such, Genauris is building a new global ecosystem for healthcare delivery and research, backed by a comprehensive, longitudinal dataset that offers an unprecedented view into emerging global health trends.

Robust support for clinical studies and health research

  • Access to a broad, highly diverse pool of global patient health data, including populations not represented in traditional datasets
  • Detailed, longitudinal health data and real-world evidence (including real-time ePROs) to streamline research efforts
  • AI-native analytical tools to support trend analysis, predictive forecasting, and therapy targeting